People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Virtual Incision Corp | — | Biotechnology | Series C | $100.8M | $53.9M | 2023 |
Mukund P. Srinivasan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mukund P. Srinivasan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Murphy | 1 | 17 |
| Steve Kirby | 1 | 6 |
| Michael Jerstad | 1 | 4 |
| Sandy Horst | 1 | 3 |
| Fernando P. Pacheco | 1 | 2 |
| Mike Jerstad | 1 | 2 |
| Tom P. Shehab | 1 | 1 |
| Fred P. Robertson | 1 | 1 |
| Tao P. Lin | 1 | 1 |
| John P. Murphy | 1 | 1 |
| Tyler P. Stowater | 1 | 1 |
| Rob P. Barmann | 1 | 1 |
| Lewei P. Wang | 1 | 1 |
| Amy P. Kobe | 1 | 1 |
| Mike P. Jerstad | 1 | 1 |
| Shane P. Farritor | 1 | 1 |
| Steve P. Kirby | 1 | 1 |
| Sandy P. Horst | 1 | 1 |
| Shi P. Shenghao | 1 | 1 |
| Dmitry Oleynikov | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.